Literature DB >> 32046610

Shifting Trends and Informed Decision-Making in the Management of Graves' Disease.

Carolyn D Seib1,2,3, Julie Chen4, Andrei Iagaru5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32046610      PMCID： PMC7074894          DOI： 10.1089/thy.2020.0114

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  41 in total

1.  Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.

Authors:  C Carella; G Mazziotti; F Sorvillo; M Piscopo; M Cioffi; P Pilla; R Nersita; S Iorio; G Amato; L E Braverman; E Roti
Journal:  Thyroid       Date:  2006-03       Impact factor: 6.568

2.  A 2013 European survey of clinical practice patterns in the management of Graves' disease.

Authors:  L Bartalena; H B Burch; K D Burman; G J Kahaly
Journal:  Clin Endocrinol (Oxf)       Date:  2015-01-09       Impact factor: 3.478

3.  Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.

Authors:  E Masiello; G Veronesi; D Gallo; P Premoli; E Bianconi; S Rosetti; C Cusini; J Sabatino; S Ippolito; E Piantanida; M L Tanda; L Chiovato; W M Wiersinga; L Bartalena
Journal:  J Endocrinol Invest       Date:  2018-06-26       Impact factor: 4.256

4.  Total thyroidectomy: a safe and effective treatment for Graves' disease.

Authors:  Jing Liu; Anna Bargren; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2011-01-26       Impact factor: 2.192

5.  Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration.

Authors:  H Allannic; R Fauchet; J Orgiazzi; A M Madec; B Genetet; Y Lorcy; A M Le Guerrier; C Delambre; V Derennes
Journal:  J Clin Endocrinol Metab       Date:  1990-03       Impact factor: 5.958

6.  Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.

Authors:  J A Franklyn; P Maisonneuve; M Sheppard; J Betteridge; P Boyle
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

7.  Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.

Authors:  Onyebuchi E Okosieme; Peter N Taylor; Carol Evans; Dan Thayer; Aaron Chai; Ishrat Khan; Mohd S Draman; Brian Tennant; John Geen; Adrian Sayers; Robert French; John H Lazarus; Lakdasa D Premawardhana; Colin M Dayan
Journal:  Lancet Diabetes Endocrinol       Date:  2019-02-28       Impact factor: 32.069

8.  Postoperative hypocalcemia after thyroidectomy for Graves' disease.

Authors:  Catherine E Pesce; Zita Shiue; Hua-Ling Tsai; Christopher B Umbricht; Ralph P Tufano; Alan P B Dackiw; Jeanne Kowalski; Martha A Zeiger
Journal:  Thyroid       Date:  2010-10-18       Impact factor: 6.568

9.  Health insurance and mortality. Evidence from a national cohort.

Authors:  P Franks; C M Clancy; M R Gold
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

10.  Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Cohort Study.

Authors:  Naomi Gronich; Idit Lavi; Gad Rennert; Walid Saliba
Journal:  Thyroid       Date:  2020-01-23       Impact factor: 6.568
View more
  3 in total

1.  Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves' Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method.

Authors:  Verena Theiler-Schwetz; Thomas Benninger; Christian Trummer; Stefan Pilz; Markus Reichhartinger
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-31       Impact factor: 6.055

2.  Machine learning identifies baseline clinical features that predict early hypothyroidism in patients with Graves' disease after radioiodine therapy.

Authors:  Lian Duan; Han-Yu Zhang; Min Lv; Han Zhang; Yao Chen; Ting Wang; Yan Li; Yan Wu; Junfeng Li; Kefeng Li
Journal:  Endocr Connect       Date:  2022-05-27       Impact factor: 3.221

3.  Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves' disease patients.

Authors:  Rui-Ting Hu; De-Shan Liu; Bin Li
Journal:  BMC Endocr Disord       Date:  2020-05-29       Impact factor: 2.763
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.